Medical therapy for children with inflam
β
Dr. Harland Winter; Richard Grand
π
Article
π
1996
π
John Wiley and Sons
π
English
β 660 KB
About 30% of individuals with inflammatory bowel disease present before the age of 21 years (1). Despite this prevalence, most therapeutic agents are tested in adults with inflammatory bowel disease and pharmacokinetics, safety, and efficacy may never be studied in children and adolescents. In this